Bivalirudin Versus Enoxaparin in Critically Ill COVID-19 Patients

NCT05334654 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Acute Respiratory Failure
SARS CoV 2 Infection
Anticoagulants

Interventions

DRUG: Enoxaparin Sodium
DRUG: Bivalirudin

Sponsor

University Magna Graecia